Leadership Overview
Hologic has 5 executives leading key functions including operations, information technology, financial management, diagnostic strategy, and diagnostic solutions.
Committed to advancing medical technology, Hologic delivers critical diagnostic and surgical tools to improve patient outcomes globally through early detection and innovative clinical care solutions.
Committed to advancing medical technology, Hologic delivers critical diagnostic and surgical tools to improve patient outcomes globally through early detection and innovative clinical care solutions.
Leadership Roles at Hologic
Karleen Oberton - Chief Financial Officer
Karleen Oberton, the Chief Financial Officer at Hologic, manages the financial health and capital allocation strategies required to sustain global medical technology leadership. Overseeing fiscal planning, the Chief Financial Officer directs investment into research and development for diagnostic products and surgical tools. This leadership role involves maintaining rigorous financial controls and reporting standards to ensure transparency for stakeholders while supporting long-term growth initiatives. By optimizing capital structure, Karleen Oberton directly impacts the company's ability to fund expansion into new clinical markets. Oberton coordinates with the executive team to align financial resources with strategic priorities in breast health and infectious disease testing. Through disciplined cost management and revenue analysis, the Chief Financial Officer secures the financial stability necessary for continuous innovation. Oberton drives the execution of financial policies that support the company's mission of improving patient wellbeing through advanced medical solutions.
Essex Mitchell - Chief Operating Officer
Essex Mitchell, the Chief Operating Officer at Hologic, directs global manufacturing and supply chain logistics to ensure the seamless delivery of medical imaging and diagnostic systems. Overseeing operational efficiency across international markets, the Chief Operating Officer optimizes production workflows to meet the rigorous demands of clinical environments. This leadership role involves coordinating with cross-functional teams to scale manufacturing capacity while maintaining strict quality standards for breast health and gynecological products. By streamlining internal processes, Essex Mitchell directly impacts the company's ability to provide timely medical solutions to healthcare providers worldwide. Mitchell manages complex distribution networks, ensuring that advanced surgical tools reach medical facilities with precision. Through rigorous oversight of operational performance, the Chief Operating Officer drives sustainable growth and supports the broader mission of enhancing patient care through reliable, high-quality medical technology manufacturing and distribution.
Jennifer Schneiders - President, Diagnostic Solutions
Jennifer Schneiders, the President, Diagnostic Solutions at Hologic, directs the commercialization and market expansion of the company's diagnostic product lines. Overseeing the business unit responsible for infectious disease testing and molecular diagnostics, the President, Diagnostic Solutions ensures that advanced testing systems reach clinical laboratories efficiently. This leadership role involves managing product portfolios and driving market penetration across diverse healthcare systems. By fostering partnerships with clinical providers, Jennifer Schneiders directly impacts the accessibility of critical diagnostic tools. Schneiders coordinates with research and development teams to prioritize product enhancements that address urgent public health challenges. Through the execution of targeted commercial strategies, the President, Diagnostic Solutions drives revenue growth and strengthens the company's market position. Schneiders manages the operational scale of the diagnostic division, ensuring that high-quality testing solutions remain available to support early detection and improved patient outcomes on a global scale.
Paul Malenchini - Chief Information Officer
Paul Malenchini, the Chief Information Officer at Hologic, architects the digital infrastructure and cybersecurity frameworks necessary to support global medical technology operations. Overseeing enterprise data systems, the Chief Information Officer ensures the integrity and security of sensitive clinical information across all diagnostic platforms. This leadership role involves integrating advanced software solutions into imaging systems to facilitate better diagnostic accuracy for healthcare professionals. By modernizing IT architecture, Paul Malenchini directly impacts the company's capacity for innovation and data-driven decision-making. Malenchini manages the digital transformation of internal business systems, fostering connectivity between regional offices and manufacturing sites. Through the implementation of robust technological safeguards, the Chief Information Officer protects critical intellectual property while enabling seamless collaboration across the organization. Malenchini drives the adoption of emerging technologies to maintain a competitive edge in the rapidly evolving medical device market.
Alistair Leonard - Vice President, Strategy & Chief Medical Officer, Diagnostics
Alistair Leonard, the Vice President, Strategy & Chief Medical Officer, Diagnostics at Hologic, architects the clinical roadmap and strategic direction for the company's diagnostic portfolio. Overseeing medical affairs, the Vice President, Strategy & Chief Medical Officer, Diagnostics ensures that all diagnostic products meet the highest standards of clinical efficacy and patient safety. This leadership role involves collaborating with healthcare professionals to identify emerging needs in infectious disease testing and gynecological care. By translating clinical insights into actionable product strategies, Alistair Leonard directly impacts the development of next-generation diagnostic tools. Leonard manages the integration of medical evidence into the product lifecycle, ensuring alignment with global regulatory requirements and clinical best practices. Through the synthesis of medical expertise and business strategy, the Vice President, Strategy & Chief Medical Officer, Diagnostics drives the expansion of the diagnostic business, ultimately helping patients receive faster and more accurate diagnoses.
Explore Leadership Teams in Manufacturing
Founded in 1919, Ottobock is a German family-owned prosthetics company that provides medical technology solutions. Products include lightweight, active, and power wheelchairs, pediatric rehabilitation products, and seating shell systems. Otto Bock also offers polyurethane foams, foam systems for the automotive industry, and information and communication technology. The company is headquartered in Duderstadt, Germany.
Company Leadership WC
PD
SH
MW
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body.
Company Leadership KB
JC
SM
DeRoyal, founded in 1973 and headquartered in Powell, Tennessee, is a manufacturer of surgical devices, unitized delivery systems, orthopedic supports and bracing, and wound care dressings.
Company Leadership PB
CS
TK
Avanos Medical is a publicly traded medical technology and healthcare products company specializing in pain management solutions, digestive health devices, enteral feeding systems, and minimally invasive medical technologies. Headquartered in Alpharetta, Georgia, the organization develops, manufactures, and markets medical devices designed to improve patient outcomes while helping healthcare providers reduce complications associated with pain therapy, nutrition delivery, and gastrointestinal care. The company primarily generates revenue through the sale of medical devices, procedural technologies, pain management systems, digestive health products, and hospital-based healthcare solutions distributed globally across acute care, surgical, and clinical healthcare settings. The company was established in 2014 following a strategic corporate separation from Kimberly-Clark Corporation healthcare operations. After becoming an independent publicly traded organization, Avanos Medical focused its operational strategy on higher-growth medical technology categories involving non-opioid pain management, digestive health innovation, and specialized clinical products. The company subsequently expanded its medical technology portfolio through acquisitions, product development investments, and commercialization initiatives designed to strengthen its position within the global healthcare technology market.
Company Leadership MG
HK
SS
SG
Frequently Asked Questions Regarding Hologic Top Executives and Leadership Team
Unlock more people and company data
